These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis. Eikani MS; Nugent M; Poursina A; Simpson P; Levy H BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189 [TBL] [Abstract][Full Text] [Related]
24. Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis. Park IK; Olivier KN Semin Respir Crit Care Med; 2015 Apr; 36(2):217-24. PubMed ID: 25826589 [TBL] [Abstract][Full Text] [Related]
25. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward. Martiniano SL; Davidson RM; Nick JA Pediatr Pulmonol; 2017 Nov; 52(S48):S29-S36. PubMed ID: 28881094 [TBL] [Abstract][Full Text] [Related]
26. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684 [TBL] [Abstract][Full Text] [Related]
27. Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany. Steindor M; Hafkemeyer S; Ruckes C; Stehling F; Naehrlich L; Ringshausen FC Int J Infect Dis; 2023 Apr; 129():32-39. PubMed ID: 36736578 [TBL] [Abstract][Full Text] [Related]
28. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view. Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary Mycobacterium abscessus: a canary in the cystic fibrosis coalmine. Haverkamp MH; van Wengen A; de Visser AW; van Kralingen KW; van Dissel JT; van de Vosse E J Infect; 2012 Jun; 64(6):609-12. PubMed ID: 22366207 [TBL] [Abstract][Full Text] [Related]
32. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection. Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608 [TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease. Park S; Jo KW; Lee SD; Kim WS; Shim TS Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447 [TBL] [Abstract][Full Text] [Related]
34. Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis. Moore JE; Millar BC Int J Mycobacteriol; 2022; 11(3):303-308. PubMed ID: 36260450 [TBL] [Abstract][Full Text] [Related]
35. Frequency and clinical significance of respiratory isolates of non-tuberculous mycobacteria in Riyadh, Saudi Arabia. Al-Harbi A; Al-Jahdali H; Al-Johani S; Baharoon S; Bin Salih S; Khan M Clin Respir J; 2016 Mar; 10(2):198-203. PubMed ID: 25130951 [TBL] [Abstract][Full Text] [Related]
36. Implication of species change of Nontuberculous Mycobacteria during or after treatment. Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802 [TBL] [Abstract][Full Text] [Related]
37. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study. Cadelis G; Ducrot R; Bourdin A; Rastogi N PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454 [TBL] [Abstract][Full Text] [Related]
39. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010004. PubMed ID: 32521055 [TBL] [Abstract][Full Text] [Related]
40. Mycobacterium abscessus and other nontuberculous mycobacteria: evolving respiratory pathogens in cystic fibrosis: a case report and review. Hayes D South Med J; 2005 Jun; 98(6):657-61. PubMed ID: 16004174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]